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Abstract 
Objectives: Recognizing and reflecting on one’s own and other people’s mental states 
represents a major difficulty for patients with Borderline Personality Disorder (BPD). Only 
recently have studies begun exploring whether these capacities increase with successful therapies 
and if such an improvement is linked with outcome. The present study investigated whether 
metacognition would improve and if its improvement was related with symptom change in BPD 
patients. 
Design: The transcripts from the first and the penultimate session of a ten-session version 
of good psychiatric management were analysed with the MAS-R scale in a N = 37 BPD sample. 
Patients, selected from a previously published RCT (Kramer et al., 2014), were assigned either to 
the good psychiatric management treatment or to the same treatment with the addition of the 
Motive-Oriented Therapeutic Relationship (MOTR; Caspar, 2007), a form of therapeutic 
relationship based on an individualized case formulation. Symptoms were assessed with the OQ-
45. 
Results: Findings partially support the hypotheses. First, improvement in capacities to 
understand others’ mind, to take a critical distance from one’s own rigid and maladaptive beliefs 
and to use behavioral and attentional strategies to face adversities is found in both treatment 
groups. Controlling for marital status, only the ability to differentiate between reality and 
representations remains significant. Second, no link between metacognitive change and symptom 
change during treatment is found. However, a link is observed between the increase in 
metacognition and symptom reduction at 6-month follow-up.  
Conclusions: Results invite to further investigate the role of metacognition in therapy 
change through different modalities and in longer-term treatments.  
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Practitioner Points 
• The development of metacognitive processes and their links with symptom change were 
examined during a short-term treatment in 37 borderline patients 
• Improvement was found in capacities to understand others’ mind, to take a critical distance 
from own rigid and maladaptive beliefs and to use behavioral and attentional strategies even 
in a short-term treatment 
• Controlling for marital status, only the ability to take a critical distance from representations 
remained significant 
• A link was observed between increase in metacognition and symptom reduction at 6-month 
follow-up 
• Understanding and tailoring interventions to specific metacognitive difficulties could be 
associated with symptom change during treatment for BPD patients 
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Following early observations by Fonagy (1991) about people presenting with BPD 
having difficulties in thinking about thinking, many researchers have investigated and developed 
considerations in this field. This capacity has been labelled under different names, such as 
metacognition (Semerari et al., 2003), which is the term we will adopt henceforth, mentalizing 
(Bateman & Fonagy, 2004), theory of mind (Carruthers & Smith, 1996), or affect consciousness 
(Choi-Kain & Gunderson, 2008). Differences in terminology notwithstanding, the key concept is 
that people with BPD may present difficulties ranging from unawareness of their own feelings 
(Joyc, Fujiwara, Cristall, Ruddy, & Ogrodniczuk, 2013; McMain et al., 2013; New et al., 2012; 
Semerari et al., 2014) to problems in correctly inferring the feelings of others as well as their 
intentions, which underlines potential problems in facial affect recognition and theory of mind 
(Choi-Kain, Fitzmaurice, Zanarini, Laverdière, & Gunderson, 2009; Petersen, Brakoulias, & 
Langdon, 2016; Semerari et al., 2005; 2015). Furthermore, difficulties in forming an integrated 
representation of the self and of others in BPD patients has long been observed and found in 
studies using different methodologies (Kernberg, 1975; Levy, Beeney, Wasserman, & Clarkin, 
2010; Outcalt et al., 2016; Semerari et al., 2014).  
We thus argue that metacognitive impairments are associated with BPD symptoms and 
that metacognition could act as a mechanism of change (Kazdin, 2009; Kramer, 2017) and be 
responsible for a part of symptom change during therapy. 
What is metacognition? 
The terms metacognition and mentalization are used in reference to the system of 
understanding, reflecting upon and regulating mental states. Metacognition involves different 
functions: a) the understanding of one’s own states of mind, b) the understanding of others’ 
states of mind and c) how individuals use these representations in order to cope with suffering 
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and resolve psychological and interpersonal conflicts (Semerari et al., 2003). It has been 
operationalized with the Metacognition Assessment Scale-Revised (MAS-R; Carcione et al., 
2010), used in the present study. Mentalization, for its part, is “the mental process by which an 
individual implicitly and explicitly interprets the actions of himself or herself and others as 
meaningful on the basis of intentional mental states such as personal desires, needs, feelings, 
beliefs, and reasons” (Bateman & Fonagy, 2004, p.21). This process has been operationalized 
with the Reflective Function scale (RF; Fonagy, Target, Steele, & Steele, 1998). 
Metacognitive impairments and Borderline Personality Disorder 
Reduced ability to make sense of mental states contributes to poor quality of 
interpersonal relationships and difficulties in forming a robust sense of identity and successfully 
pursuing long-term plans (Bateman & Fonagy, 2004; Lysaker et al., 2014; Semerari et al., 2003): 
if a a person has negative anticipations about the motives underlying other people’s behavior, for 
example thinking the other is cheating or abandoning, and cannot question the truth-like quality 
of these attributions, it is hard to form secure relationships or to regulate the negative emotions 
evoked by such scenarios.  
Problems in the ability to make sense of mental states could sustain BPD symptoms such 
as emotional dysregulation, impulsivity or self-harm (Bateman & Fonagy, 2004; Fonagy, 
Luyten, & Bateman, 2015; Semerari et al., 2014). Studies also identified that all areas of the 
metacognitive system may be impaired (Joyce et al., 2013; McMain et al., 2013; New et al., 
2012). Moreover, the ability to form a mature and nuanced understanding of other people’s mind 
is consistently impaired when analysed with tasks involving complex scenarios (Brüne et al., 
2016; Outcalt et al., 2016), mirroring real life conditions (Sharp et al., 2016), or when analysing 
patient interviews and session transcripts (Levy et al., 2006; Semerari et al., 2005; 2015). Finally, 
METACOGNITION AND SYMPTOM CHANGE IN BPD 
 6 
  
the ability to regulate mental states, including emotions, is also limited in this population 
(Carcione et al., 2011; Lysaker et al., 2014; Outcalt et al., 2016; Scott, Stepp, & Pilkonis, 2014). 
Taking all these into account, difficulties in understanding and reflecting on mental states 
have been defined as an important treatment target for BPD population (Bateman & Fonagy, 
2004; Dimaggio, Semerari, Carcione, Nicolò, & Procacci, 2007; Fonagy, Luyten, & Bateman, 
2015). 
Metacognition and psychotherapy outcome 
As many symptoms and interpersonal problems presented by patients suffering from BPD 
are correlated with reduced metacognition, studies have focused on this relationship in two 
different ways: metacognition is either postulated as an outcome predictor or a moderator factor 
in BPD treatments.  
As a possible outcome predictor, findings concerning the assumption that higher 
metacognitive abilities at treatment onset are associated with a more pronounced symptom 
reduction in BPD patients are still mixed. For example, alexithymia, the poor capacity to identify 
and describe one’s own emotions (Talyor, Bagby, & Parker, 1997) was found to be an outcome 
predictor in Ogrodniczuk, Piper, and Joyce's (2011) study. However, this finding was not 
replicated by Joyce and colleagues (2013). Two studies showed rather a moderator effect of 
mentalization abilities on patients’ outcome in terms of social functioning, symptom distress, 
interpersonal problems and psychosocial functioning. Gullestad, Johansen, Høglend, Karterud, 
and Wilberg (2013) found that patients with avoidant PD and/or BPD, and presenting a low level 
of reflective functioning at baseline, improved their psychosocial functioning when assigned to 
an outpatient treatment (individual therapy, flexible format) compared to a step-down treatment 
(day hospital treatment and outpatient group and individual therapies). They did not find a 
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predictor effect of reflective functioning on outcome. A 6-year follow-up on the same sample 
replicated the previous results, namely a moderator and no predictor effect of reflective 
functioning (Antonsen et al., 2016). 
However, studies focused on predictor and moderator factors provide no deeper 
explanation on how change occurs during therapy. Indeed, the idea is that first patients come to 
understand in a deeper way their mental states and those of others, and then they use this 
capacity for the sake of symptom relief and behavioral change (Bateman & Fonagy, 2004; 
Semerari et al., 2007), change in metacognition being correlated with symptom reduction.  
Fischer-Kern et al. (2015) compared BPD patients who received either transference-
focused psychotherapy or a treatment by experienced community therapists. Changes in 
reflective functioning was negatively linked with changes in personality organization. Recently, 
De Meulemeester, Vansteelandt, Luyten, and Lowyck (2017) examined mentalization as a 
predictor and as a mechanism of change in a long-term hospitalization-based psychodynamic 
treatment for BPD patients. Levels of mentalization at onset did not predict symptom change but 
a strong correlation was observed between change in symptomatic distress and change in 
uncertainty about mental states.  
In a pilot study, pre-post therapy session transcripts of 10 BPD patients were analysed 
with the MAS-R (Maillard et al., 2017). The findings, to be taken cautiously, showed significant 
improvement in the metacognition’s mastery function and a link between the level of 
understanding of others’ mind at the treatment onset and better outcomes after a short-term 
treatment.  
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Change in metacognition through psychotherapy 
In the light of the above, we hypothesize that improvement in the capacity to make sense 
and regulate mental states might explain a part of good therapeutic outcomes. As therapy 
progresses, patients should learn how to better identify their emotions, their cognitions and 
question their attributions as well as to use psychological information for the sake of a more 
adaptive self-regulation (Carcione et al., 2011; Dimaggio et al., 2009; Kramer, 2016; Kramer, 
Keller, Caspar, de Roten, & Despland, 2017; Neacsiu, Rizvi, & Linehan, 2010; Semerari et al., 
2005). In other words, good outcome psychotherapy should be likely to promote an increase in 
mentalistic capacities in different kinds of treatment (Carcione et al., 2011; Fischer-Kern et al., 
2015; Levy et al., 2006). 
Two previous RCTs explored the evolution in mentalization in BPD patients during 1 
year of therapy. Levy et al. (2006) highlighted a significant improvement in reflective 
functioning, as assessed in adult attachment interviews (Fonagy, Target, Steele & Steele, 1998) 
for patients treated with transference-focused psychotherapy, whereas individuals assigned to 
dialectical behavior therapy and supportive therapy did not show such a change. A significant 
increase in mentalization was found only in patients treated with transference-focused therapy in 
Fischer-Kern et al. (2015).  Other studies did not show evidence for such an improvement in 
mentalization, for example in a psychoanalytic treatment for hospitalized patients presenting 
with a PD (73% of whom belonged to cluster B; Vermote et al., 2010; 2011).  
Change in short-term treatments 
The majority of the studies focused on possible mentalistic improvement have analysed 
periods ranging from 4 months to years of therapy (Antonsen et al., 2016; Carcione et al., 2011; 
Fischer-Kern et al., 2015; Gullestad et al., 2013; Levy et al., 2006; Vermote et al., 2010; 2011). 
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The question remains open about how fast such an improvement can be achieved and little is 
known about very early metacognitive changes in psychotherapy, even if brief treatments have 
demonstrated effects on initial symptom relief. For example, Kramer et al. (2014) analysed the 
impact of the Motive-Oriented Therapeutic Relationship (MOTR; Caspar, 2007) in the context of 
a 10-session version of a general treatment for patients presenting with BPD. MOTR stems from 
the Plan Analysis (PA) method, which is an individualized case formulation inferred from the 
patients’ verbal and non-verbal behaviors (for a detailed prototypical PA of BPD, see Berthoud 
et al., 2013). A therapeutic relationship, which is developped on the basis of the PA, is then 
offered to the patient. It was shown that MOTR had a small but significant effect on symptom 
reduction. Whether early therapeutic changes are possible is a question that has to be examined 
to get a better comprehension of the therapeutic levers playing a role in BPD treatments. 
Goals and hypotheses of the present study 
The present study aims at exploring the metacognitive change and its links with 
therapeutic outcome in a 10-session treatment, which is a condensed version of Good Psychiatric 
Management (GPM; Gunderson & Links, 2014). We want to explore whether early changes in 
metacognition appear in a treatment that does not specifically focus on its improvement. We also 
want to examine whether metacognitive change is linked with symptom change, even in such a 
short therapy period. The two main hypotheses for the present study are: 
1. Metacognition improves during a short-term treatment 
2. The increase in metacognition is correlated with symptom reduction, especially interpersonal 
difficulties 
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Method 
Design 
The present study represents a secondary process-outcome analysis based on a RCT 
(Kramer et al. 2014, N = 85), using a sub-sample of a process-outcome mediation analysis 
(Kramer et al., 2017, N = 57). The study was offered to each adult (between 18 and 65 years of 
age) addressed to a specialized center for borderline personality disorder, which was part of an 
outpatient university psychiatric clinic.  
Patients were randomly allocated either to the manualized short-version of the GPM 
(GPM condition) or to the same treatment to which MOTR was added (GPM + MOTR 
condition). Randomization was executed with an internet-based block randomization program, 
and an independent researcher prepared sealed envelopes that were opened once the patient has 
accepted to participate to the study. The protocol was approved by the ethic board (clearance 
number 254/08) and by the research comittee of the university department. Moreover, the 
participants did not pay for their treatment, according to the national law. The drop-out rate was 
13% (Kramer, 2014).  
Participants 
Twenty participants from the Kramer et al. (2017) study were excluded because either the 
tape recorded session was a structured assessment (diagnosis, suicidal risk, addiction) or for 
other exclusion criteria (presence of a translator or of co-morbid head injury). 
Of the 37 remaining patients (all completers from Kramer et al. 2014), 17 belonged to the 
GPM condition and 20 to the GPM + MOTR condition (Table 1). At baseline, groups did not 
differ in terms of age (t1,37 = -.016, p = .98), gender (χ2  = 2.2, p = .14), employment (χ2 = 3.9, p = 
.27), number of BPD criteria (t1,37 = -.08, p = .94), number of diagnoses on axis I (t1,37 = .11, p = 
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.91) and II (t1,37 = .36, p = .72), level of OQ-45 symptoms (t1,37 = -.99, p = .33) and level of 
metacognition at intake (t1,37 = 1.74, p = .09). Patients from the GPM + MOTR condition were 
more frequently married than the GPM group (χ2   = 9.76, p < .05). Comorbid diagnoses were 
assessed by trained clinicians with the Mini International Neuropsychiatric Interview (Lecrubier 
et al., 1997) for DSM-IV axis I and the SCID-II (First & Gibbon, 2004) for DSM-IV axis II. On 
average, patients had 7.08 (SD = 1.5) BPD criteria. 
Therapists 
A total of 10 therapists were in charge of the GPM-based treatment in the GPM 
condition: 3 therapists treated respectively 5, 3, and 2 patients, and 7 therapists treated 1 patient. 
For the GPM + MOTR condition, 5 therapists treated respectively 8, 6, 3, 2, and 1 patients. They 
were 6 psychiatrists and 6 psychologists with at least 1 year of psychiatry residency and a basic 
psychodynamic background. 3 therapists were nurses. 
Treatments 
GPM condition: Patients received a 10-session treatment which constitutes a short 
version (Kolly et al., unpublished) of the GPM for BPD (Gunderson & Links, 2014). The 
majority of patients received additional treatment after the 10 sessions. GPM was used as a 
useful first-line treatment and a preparation for long-term psychotherapy. It focuses on: 
communication about psychiatric diagnoses, comorbidities and psychiatric anamnesis, definition 
of the main problems and treatment targets, identification of treatment objectives, recognition of 
and dealing with difficulties interfering with the treatment and finally formulation of the 
relational interpretations of core conflictual themes.  
GPM + MOTR condition: This condition is the same as the GPM, with the 
implementation of Plan Analysis (PA), an integrative case formulation method, and MOTR 
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techniques that are intervention heuristics consistent with the patients’ PA (Caspar, 2007). Based 
on PA, the therapist individualizes the therapeutic relationship he offers, and MOTR enables the 
satisfaction of the patient’s needs in the therapy (in the limits of the therapeutic relationship) 
without reinforcing problematic behaviors generally used by the patient. Using MOTR, the 
therapist thus ensures a setting in which the patient does not need to use his/her problematic 
means to reach his/her motives or needs. 
Treatment adherence: Treatment adherence for GPM was assessed with the General 
Psychiatric Management Adherence Scale (Kolla et al., 2009), filled by therapists after 
treatment. Treatment integrity was high for the GPM condition (M = 4.32, SD = 0.3) and for the 
GPM + MOTR condition (M = 4.37, SD = .26). Inter-group difference was not significant (t1,38 = 
.58, p = .57). 
Treatment adherence for the MOTR was measured with the observer-rated method of 
Plan Analysis and the Motive-Oriented Therapeutic Relationship scale (Caspar, Grossman, 
Unmussig, & Schramm, 2005). It is based on the accuracy of the therapist concerning the 
patient’s PA. Results showed a strong MOTR adherence in the GPM + MOTR condition (M = 
1.55, SD = .04) and a moderate MOTR adherence for the GPM condition (M = 0.45, SD = .38). 
This difference was significant (t1,59 = 10.62, p<.001). 
Instruments 
The Outcome Questionnaire-45.2 (OQ-45; Lambert et al., 2004) is a self-report 
questionnaire designed for assessing three domains of mental health functioning and their 
evolution during treatment: symptom distress, interpersonal functioning and social role. Items 
are assessed on a 4-point Likert scale, ranging from 1 (never) to 4 (always). A global score and 
scores for each subscale are computed. The cut-off for the global score is 63, 36 for symptom 
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distress, 15 for interpersonal relationships and 12 for social role. The questionaire was given 
after the first and the penultimate sessions and was filled in between two sessions, at home. 
Cronbach’s alpha was α = .94 for the present study and α = 0.94 in the literature (Boswell, 
White, Sims, Harrist, and Romans, 2013). 
The Metacognition Assessment Scale-Revised (MAS-R; Carcione et al., 2010) is an 
observer-rating scale that assesses change in metacognitive capacities as manifested in 
individuals’ narratives. It provides a global score and a score for three main subscales with 
several subfunctions: 
1) Understanding of one’s own Mind (UM subscale) measures the ability of a person to think 
about his own mental states. It includes 1) Monitoring, that is the ability to recognize and 
describe cognitive and emotional states and the links between them; 2) Differentiation which 
is the distinction between reality and representations; 3) Integration, which is the ability to 
construct an integrated view of the self. 
2) Understanding of Other’s Mind (UOM subscale) assesses the capacity to think about others’ 
mental states. It includes 1) Monitoring, that is the identification of other’s cognitions, 
emotions and the possible links between them and other’s behavior; 2) Decentration, or the 
possibility to hypothesize about other’s states of mind which are independent from our own 
point of view or our involvement in the relationship. 
3) Mastery (M subscale) represents the adoption of an active attitude to use mentalistic 
knowledge to soothe suffering and solve conflicts. It includes three different levels, from a 
more behavioral to a more metacognitive level.  
Each subfunction is rated on a 5-point Likert scale ranging from 1 = “scarce” (sporadic, 
poorly articulated, not spontaneous, probing does not generate improvement) to 5 = 
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“sophisticated” (sustained talk about mental states, descriptions are rich, talk of mental states is 
spontaneous or there is an autonomous elaboration of a question/suggestion). If a subfunction 
does not appear in the transcript, the rater has the possibility to score it as “Not Engaged”. 
Cronbach’s alpha was α = .94 for the present study and .91 for the pilot study (Maillard et 
al., 2017). 
Procedure 
The first and penultimate sessions of each of the 37 patients were tape-recorded and 
transcribed (Mergenthaler & Stigler, 1997). The therapist was in charge of the recordings. Data 
treatment and storage were done according to standard ethical procedures, accepted by the ethic 
board. Thus, a total of 74 transcripts were analysed with the MAS-R. 
MAS-R assessment and rating 
Each transcript was split into interaction units, and two independent raters, along with a 
Master’s degree student, scored each unit with the MAS-R. All were blinded to the treatment 
condition. One rater is one of the developers of the MAS-R and another is a psychologist with 5 
years of clinical and research experience who was trained for 6 months in the MAS-R scoring. 
They were all blind to any details regarding participants and sessions. A consensus score was 
then used for the data collection. 
Statistical analyses 
Inter-rater reliability was analysed using Intra-Class Coefficients (Shrout & Fleiss, 1979). 
Pearson’s correlations were used between the MAS-R subscales to observe the links between 
them. Paired t-tests were conducted to assess the potential differences between the scoring units 
of the MAS-R. Finally, independent t-tests were done to test the symptom change, and Pearson’s 
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correlations between the OQ-45 and the MAS-R scores at intake were used to observe the 
relationship between symptoms and metacognition at treatment onset.  
For the first hypothesis, repeated measures analyses of variance (rm ANOVA) were 
conducted to analyse intra and inter-group differences between MAS-R subscales at intake and at 
discharge. Marital status was added as a co-variate variable in repeated measures analyses of 
covariance (rm ANCOVA). 
For the second hypothesis, the link between metacognitive and symptom changes, 
Pearson’s partial correlations were used on the delta scores of OQ-45 and MAS-R. These scores 
were obtained by subtracting scores at discharge from scores at intake. Scores at intake were 
entered as controlled variables. Analog analyses were carried out on outcome defined as 
symptom change between discharge and 6-month follow-up. 
Both hypotheses were tested on the full sample taking into account the relevant 
covariants. For exploratory purposes, each condition (GPM and GPM + MOTR) was also 
analysed separately. For that point, an analysis of covariance (ANCOVA) and Pearson’s partial 
correlations, followed by Fisher’s z transformation, were compared to explore possible inter-
group differences. 
Results 
Preliminary Analyses 
First, inter-rater reliability of the MAS-R was calculated for 20% of the transcripts (n = 
15) with Intra-Class Coefficients. It was considered good, with a mean ICC (2,1) = .81 (SD = 
.17, range = .65-.96). Second, the relationship between the three subscales of the MAS-R (UM, 
UOM, M) was analysed for all patients (N = 37) and significant Pearson’s correlations were 
found at intake: UM correlates with UOM (r =.73, p <.001), and with M (r = .84, p <.001), and 
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UOM correlates with M (r = .73, p <.001). Significant correlations were also found at discharge: 
UM correlates with UOM (r =.85, p <.001), and with M (r = .89, p <.001), and UOM correlates 
with M (r = .75, p <.001). Third, paired t-tests were conducted to assess the differences between 
the scoring units (part 1, 2 and 3 of each session) of the MAS-R. No significant difference was 
found (t range = .03 - 1.94, all NS). Fourth, change in OQ-45 was analysed for the entire sample 
by comparing global scores at intake and at discharge. Globally, patients showed a significant 
decrease in symptoms: M at intake = 98.5, SD = 26.4, and M at discharge = 83.1, SD = 25.4 (t = 
4.47; p <.001). The GPM group did not statistically improve in terms of symptoms (intake: M = 
93.8, SD = 28; discharge: M = 84.8, SD = 27; t = 1.61, p =.12). However, the GPM + MOTR 
group did improve significantly (intake: M = 102.4, SD = 24.8; discharge: M = 81.7, SD = 23.9; t 
= 5.25, p <.001). Finally, links between OQ-45 and MAS-R at intake were analysed with 
Pearson’s correlations. A negative correlation was found between OQ-45 total score and MAS-R 
total score (r = -.301, p = .03). 
Metacognitive change during treatment 
The first hypothesis was that metacognition improves during treatment. Means and 
standard deviations for the MAS-R global and subscales scores at intake and at discharge are 
presented in Table 2. Rm ANOVA were first conducted to test the difference between the MAS-
R scores at intake and at discharge for both groups. We found significant improvement for the 
main subscale Understanding of Other’s Mind (UOM): F(1,34) = 6.02, p = .02, ES pre-post d = 
0.53 (GPM d = 0.49; MOTR d = 0.57). Analyses were also made at the subfunction level and 
revealed significant improvement for the UOM subfunction Monitoring: F(1,34) = 7.75, p = 
.009, ES pre-post d = 0.60 (GPM d = 0.56; MOTR d = 1.19), for the Understanding one’s own 
Mind subfunction Differentiation: F(1,32) = 6.96, p = .013, ES pre-post d = 0.62 (GPM d = 0.51; 
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MOTR d = 0.73) and the Mastery subfunction Second level strategies: F(1,15) = 4.49, p = .05, 
ES pre-post d = 0.62 (GPM d = 0.58; MOTR d = 0.71). 
Rm ANCOVA were then used with marital status as covariate variable. Only the change 
for the UM subscale Differentiation remained significant: F(1,31) = 4.48, p = .04, d = 0.62 
(Table 2); married patients showed a greater change in terms of metacognition compared to 
single or divorced patients. No difference between GPM and GPM + MOTR groups was found 
for Differentiation change across treatment: F(1,31) = .294, p = .59. We made additional 
analyses to control that there were no difference at intake between married and single/divorced 
patients on the OQ-45: independent t-tests were non-significant: F(1,35) = .81, p = .75, d = 0.08. 
Metacognitive and symptom changes 
Our second hypothesis was that the greater the metacognitive increase, the greater the 
symptom reduction. First, MAS-R change and OQ-45 were computed in delta MAS-R score and 
delta OQ-45 score. Pearson’s partial correlations were then conducted to explore the gradient 
between metacognitive change and symptom change, controlling for MAS-R and OQ-45 scores 
at intake. No significant partial correlation was found (Table 3). As for our first hypothesis, we 
explored the differences between the GPM and the GPM + MOTR groups concerning the link 
between metacognitive and symptom changes. No partial correlation was significant between 
delta MAS-R and delta OQ-45 when both groups were compared (transformed z range = -0.42-
1.25, M = 0.50, SD = 0.57). 
Finally, Pearson’s partial correlations were conducted between delta MAS-R and 
symptom change during the 6-month follow-up (OQ-45 score at 6-month follow-up – OQ-45 
score at discharge), controlling for MAS-R score at intake and OQ-45 score at discharge. 
Analyses were made on n = 20 participants (8 were part of the GPM group and 12 of the GPM + 
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MOTR group), due to missing values at follow-up (Kramer, Stulz et al., 2017). A negative 
correlation was found between delta MAS-R and delta OQ-45: r = -.403, p = .049, suggesting 
that the greater the MAS-R improvement during treatment, the greater the symptom reduction 
during follow-up. Identical analyses were made on the OQ-45 subscales. They revealed a 
negative correlation between delta MAS-R and the Interpersonal Relationships subscale (r = -
.489, p =.02).  
Discussion 
In the present study, we first hypothesized an increase in the ability to recognize mental 
states in the self and in others, to form complex and integrated ideas of the self and others, and to 
use mentalistic knowledge for a purposeful problem solving in a short-term treatment for BPD. 
The second hypothesis was that the metacognitive improvement was linked to symptom change 
presented by patients. Two main results were found. First, using a strict and controlled model, 
we highlighted that married borderline patients show a greater improvement in terms of 
metacognition, compared to single or divorced patients. Secondly, links were found between 
metacognitive change during treatment and symptom reduction during the 6-month follow-up 
period. 
Change in metacognition 
Including the marital status as a covariate variable, we found a significative change for 
the Differentiation variable. This is an important point for the understanding of the therapy 
process, particularly with BPD patients, as it involves the capacity to consider one’s own 
thoughts as hypotheses and not necessarily as mirroring reality. Indeed, BPD patients tend to 
show overconfidence in their conclusions, especially when they assign negative intentions to 
other people (Baer et al., 2012; Barnow et al., 2009). The treatment used in the present study 
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seems to have been helpful to reduce such biases and promote the capacity to self-observe from a 
different perspective. Of note, given that differentiation remained low at therapy outset, it is 
likely that the change obtained was simple, e.g. patients just passed to ideas such as: “Others will 
abandon me for sure as they are mean to me” to “Maybe I am over-concerned about 
abandonment”. Furthermore, the marital status seems to represent a moderator variable of our 
results. Indeed, married patients showed a greater Differentiation change compared to single or 
divorced patients. It is possible that the relationship and the daily life shared with a partner 
promotes, as the therapeutic setting, a distanciation regarding patients’ hypotheses and 
representations, not forgetting of the impact of satisfaction and support associated with marriage 
on mental health (Holt-Lunstad, Birmingham, & Jones, 2008). 
In a less controlled pattern of analyses, a significant increase in the ability to understand 
other people’s mental states (UOM) was also found, independent of treatment group. As 
treatment was not devised to promote awareness of others’ states of mind, it is possible that this 
improvement was driven by non-specific factors, such as a good therapy relationship. But 
treatment may also have promoted an initial correction of BPD biases, such as over-attribution of 
hostility in the others and mistrust (Baer, Peters, Eisenlohr-Moul, Geiger, & Sauer, 2012; 
Hidalgo et al., 2016). Moreover, two MAS-R subscales improved: the identification of other’s 
cognitions and emotions (UOM Monitoring) and the ability to deal with difficulties imposing or 
inhibiting a behavior on oneself or using a distraction (Second level strategies).  
Metacognition as a mechanism of change 
Regarding metacognition as a possible mechanism of change during treatment, results 
were not conclusive: metacognitive change was not linked with symptom reduction. Again, this 
may be specific to the treatment adopted here, as symptom change may have been obtained by 
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psychoeducational aspects that patients learnt and which helped them to better deal with crises. 
Moreover, symptom change was relatively small and did not result in better and healthier 
interpersonal functioning. It is still possible that with more time an increase in metacognition 
may predict symptom change in the long term, especially in the area of social relationships. 
Of course, we cannot rule out the hypothesis that overall metacognition simply does not 
act as a mechanism of change, as our main finding nuances De Meulemeester et al.’s (2017) 
study where a strong association was found between improvement in mentalizing and symptom 
change during treatment. Part of that difference could be explained by the nature of the method 
used, in addition to conceptual divergence of how the potential mechanism of change was 
defined. Indeed, while self-questionnaires were used in the De Meulemeester et al. (2017) study, 
an observer-rating scale was adopted here. We presume that it provides a different evaluation of 
metacognition than self-questionnaires and the biases they involve. It follows Kramer (2017) 
who notifies, in order to be clinically meaningful, that the process perspective on personality 
disorder should ideally emphasize the use of an independent observer’s viewpoint through the 
use of video or audio transcripts of therapeutic sessions to understand therapy change in 
personality disorders.  
Though metacognitive improvement was not related to symptom change through the 10-
session treatment, it was linked with the symptom change that took place during the 6-month 
follow-up period. This medium-term effect may mean that through treatment and relationship 
with their therapists, patients have learnt to reflect on their mental states and those of others’, and 
time was needed to integrate those new aspects and to potentiate a reduction of interpersonal 
difficulties, as experienced by patients. This finding highlights the close connection between 
metacognitive capacities and interpersonal issues presenting by patients suffering from BPD. 
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The present study has several limitations. First of all, our sample was composed of 70% 
of women, which reduces the generalizability of the results. Moreover, our sample was a very 
low functioning one, therefore replication is needed with higher functioning population and a 
control group. Furthermore, high correlations were found between the three MAS-R subscales at 
intake and at discharge. This raises the issue of whether the use of the MAS-R global score only 
was the best way to assess metacognition in our sample. A measurement of alexithymia could 
also be added in the protocol in order to enrich the assessment of metacognitive domains. Of 
note, metacognition capacities do not only rely on patients but also depend strongly on the 
therapist’s ability to adapt his/her own metacognitive level to the patient’s in order to improve 
and develop it (Bateman & Fonagy, 2006; Dimaggio et al, 2015). As therapists’ interventions 
and their responsiveness to metacognitive problems were not assessed, we cannot rule out the 
possibility of therapist contribution to our findings. Another limitation is that 15 therapists 
delivered treatment, which brings the possibility of a large variability in the quality of therapies 
administered. Further exploration of the role of the therapists is thus needed. Finally, our results 
speak for a very specific treatment model for BPD, which was not tailored to promote awareness 
of mental states. Therefore, results cannot be generalized to patients undergoing other treatments. 
In spite of the acknowledged limitations, this study expands results from a recent pilot  
study (Maillard et al., 2017) and provides evidence that some metacognitive aspects can improve 
during psychotherapy for BPD, even in a period as short as 3 months (see Edel et al. 2017 for 
parallel findings). Conversely, the magnitude of metacognitive change was quite small and 
specific to selected aspects of metacognition. Future research should continue to investigate 
other therapy modalities and use longer-term treatments in order to explore if metacognition 
evolves during successful therapies. Overall, there is the promise that tailoring interventions to 
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specific metacognitive impairments, which implies a high degree of therapist responsiveness, 
metacognition would improve more and be more strongly connected to symptom change. 
Research is also needed to explore whether metacognition acts through its impact on the therapy 
relationship, as patients having less mentalistic capacities are likely to have more difficulties 
forming a task-oriented alliance with their therapists, this last issue being the next goal of our 
research program.  
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Table 1 
Patients’ characteristics at intake (N = 37) 
 Group 
Variables GPM (n = 17) GPM + MOTR (n =20) 
Age          33.7 (1.18) 33.8 (1.4) 
Gender   
Female 14 (82.4) 12 (60) 
Marital Status   
Single 11 (64.7) 3 (15) 
Married 3 (17.6) 10 (50) 
Divorced 3 (17.6) 7 (35) 
Employment 
Unemployed 
Protected activity 
Part-time  
Full-time 
 
15 (88.2) 
0 (0) 
1 (5.9) 
1 (5.9) 
 
12 (60) 
1 (5) 
3 (15) 
4 (20) 
Medication 
Yes 
 
16 (94) 
 
14 (70) 
DSM-IV axis I diagnoses 
Depressive disorder1 
Substance abuse 
Anxiety disorder2 
Eating disorder 
Attention deficit  
Sexual disorder 
 
10 (58.8) 
9 (52.9) 
5 (29) 
0 (0) 
1 (5.9) 
1 (5.9) 
 
17 (85) 
5 (25) 
4 (20) 
3 (17.6) 
0 (0) 
0 (0) 
DSM-IV axis II diagnoses 
Cluster A 
 
3 (17.6) 
 
3 (15) 
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Cluster B 
Cluster C 
4 (23.5) 
2 (11.8) 
2 (10) 
4 (20) 
Fulfilled BPD criteria 7.06 (1.48) 7.10 (1.59) 
 
Values are expressed as numbers (percentages in parentheses) or as means and SD. 
1 Including chronic depression and dysthymia 
2 Including generalized anxiety disorder, post-traumatic stress disorder, panic disorder with agoraphobia and social 
phobia 
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Table 2 
Means, standard deviations, and change of MAS-R scores obtained by patients at admission and at discharge (N 
=37) 
MAS-R scales 
Admission 
 mean   (SD) 
Discharge 
mean   (SD) 
                    
F1 
                     
p value ES 
MAS-R total score 1.65 (0.47) 1.81 (0.52) .73 .39 0.32 
Understanding of one’s own mind 
Monitoring 
Differentiation 
Integration 
1.81 (0.54) 
2.1 (0.67) 
1.32 (0.49) 
1.41 (0.54) 
2 (0.60) 
2.25 (0.72) 
1.66 (0.60) 
1.60 (0.54) 
1.26 
.49 
4.47 
2.09 
.26 
.49 
.043 
.16 
0.33 
0.21 
0.62 
0.35 
Understanding of Other’s mind 
Monitoring 
Decentration 
1.40 (0.43) 
1.42 (0.45) 
1.33 (0.56) 
1.65 (0.50) 
1.74 (0.60) 
1.37 (0.45) 
2.36 
2.62 
.12 
     .13 
.12 
.73 
0.53 
0.60 
0.07 
Mastery (M) 
Basic requirements 
1st level strategies 
2nd level strategies 
3rd level strategies 
1.59 (0.50) 
1.82 (0.72) 
1.54 (0.44) 
1.57 (0.52) 
1.59 (0.65) 
1.65 (0.50) 
1.87 (0.62) 
1.54 (0.50) 
1.95 (0.69) 
1.60 (0.60) 
0 
.01 
.35 
.55 
.08 
.99 
.93 
.56 
.48 
.77 
0.12 
0.07 
0 
0.62 
0.01 
1df for MAS-R total score = 1,34; Understandinf of one’s own mind = 1,34; UM Monitoring = 1,34; Differentiation 
= 1,31, Integration = 1,30; Understanding of Other’s mind = 1,33; UOM Monitoring = 1,33; Decentration = 1,28; 
Basic requirements = 1,34; 1st level strategies =1,33; 2nd level strategies = 1,14; 3rd level strategies = 1,26. 
 
 
;  
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Table 3 
Pearson’s partial correlations (r) of metacognition change (delta MAS-R) and symptom change (delta OQ-45 
subscales)(N = 37) 
 Symptom Distress Interpersonal Relationships 
Social 
Relationships 
UOM 
 
Differentiation 
 
UOM Monitoring 
 
Second level strategies 
.046 
 
-.048 
 
.031 
 
-.263 
.096 
 
.153 
 
.302 
 
-.428 
-.092 
 
.088 
 
-.083 
 
-.206 
 
Deltas = deltas between pre and post measures 
 
 
 
